(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Wnt/β-catenin-mediated inhibition of cardiogenesis in
Xenopus is via GATA4/6 function. Gene expression analysis at
stage 32 by RT-PCR of animal cap explants, injected with RNA encoding Activin
(Act, 50 fg) to induce cardiogenesis (A), dorsal marginal zone (DMZ) explants
(B) and whole embryos (C), which were injected with β-cateninGR
(βGR, 50 pg), GATA4GR (G4GR, 200 pg) or GATA6GR (G6GR, 200 pg), as
indicated, and were cultured with dexamethasone from stages 8, 10 or 18 where
indicated. Activation of β-catenin abolishes activin-induced (A)
and endogenous (B) expression of GATA4 and GATA6, as well as
cardiogenesis, as monitored by marker gene expression. (C) In whole
embryo analysis, activation of β-catenin abolishes heart muscle-specific
differentiation markers (MLC2, TnIc), but causes only a relatively weak
reduction of markers that are not exclusively heart specific (GATA4, GATA6,
Wnt11, Nkx2-5). However, β-catenin-mediated inhibition of cardiogenic
marker gene expression is rescued by concomitant activation of GATA4GR or
GATA6GR in all three assays. N/D, not determined; VMZ, ventral marginal zone
explant.